Indeed, our database analysis shows that there is a statistically significant relationship (p < 0.05, r = −0.27) between the reduced expression of BRCA1 and the reduced expression of NORE1A in Her2+, but not Her− breast cancers (Breast Cancer Gene-Expression Miner v3.2) [46]. The gene discussed is RASSF5; the disease is breast carcinoma.